Au Small Finance Bank Regulatory Approval

Earnings Call

Au Small Finance Bank Earnings Call Transcript: Key Takeaways

AU SFB shows strong growth momentum despite a tight liquidity environment. Management is focused on granular deposit mobilization and leveraging technology to improve operating efficiency.

Call

Guides 25% growth

Results Update

Au Small Finance Bank Results Update

AU Small Finance Bank filed a press release on its unaudited Q2 and H1 FY27 results, reporting PAT up 53% YoY to ₹858 cr. The filing is a continuation of the results disclosure, with the results figures themselves carried in the release.

Financial Results

Au Small Finance Bank Q2 FY27 Results: Net Profit ₹857.7 Cr, Up 52.9% YoY

Au Small Finance Bank Ltd reported revenue from operations of ₹5,612 Cr (+24.4% YoY) and net profit of ₹857.7 Cr (+52.9% YoY) for Q2 FY27.

Key figure

Net profit ₹857.7 Cr · +52.9% YoY

Debt & Borrowing

Au Small Finance Bank Debt & Borrowing: ₹0.53 Cr

AU Small Finance Bank paid Rs.0.53 Crore monthly interest on its 10.70% NCDs on the due date. Payment frequency is unchanged.

Value

₹0.53 Cr

Other Announcement

Au Small Finance Bank Other Announcement

This is a quarterly shareholding pattern filing providing updated stake details for AU Small Finance Bank Ltd as of September 30, 2026.

Employee Stock Options

Au Small Finance Bank Employee Stock Options

AU Small Finance Bank allotted 4,03,913 equity shares following the exercise of employee stock options. This increases the bank's total paid-up equity share capital.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.